UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Decreased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.5% in the second quarter, Holdings Channel reports. The institutional investor owned 2,266,194 shares of the healthcare conglomerate’s stock after selling 107,234 shares during the period. UnitedHealth Group accounts for 1.1% of The Manufacturers Life Insurance [...]

featured-image

The Manufacturers Life Insurance Company lowered its position in shares of UnitedHealth Group Incorporated ( NYSE:UNH – Free Report ) by 4.5% in the second quarter, Holdings Channel reports. The institutional investor owned 2,266,194 shares of the healthcare conglomerate’s stock after selling 107,234 shares during the period.

UnitedHealth Group accounts for 1.1% of The Manufacturers Life Insurance Company’s holdings, making the stock its 8th biggest holding. The Manufacturers Life Insurance Company’s holdings in UnitedHealth Group were worth $1,154,082,000 as of its most recent SEC filing.



A number of other institutional investors and hedge funds have also made changes to their positions in the company. Matrix Private Capital Group LLC increased its position in UnitedHealth Group by 3.6% during the 2nd quarter.

Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 19 shares during the period. Dark Forest Capital Management LP raised its position in UnitedHealth Group by 76.9% in the second quarter.

Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after acquiring an additional 319 shares in the last quarter. Deprince Race & Zollo Inc. boosted its position in shares of UnitedHealth Group by 24.

7% during the 2nd quarter. Deprince Race & Zollo Inc. now owns 69,694 shares of the healthcare conglomerate’s stock worth $35,492,000 after purchasing an additional 13,815 shares in the last quarter.

Decatur Capital Management Inc. increased its holdings in shares of UnitedHealth Group by 2.7% in the 2nd quarter.

Decatur Capital Management Inc. now owns 7,079 shares of the healthcare conglomerate’s stock valued at $3,605,000 after purchasing an additional 189 shares in the last quarter. Finally, Delta Investment Management LLC grew its position in UnitedHealth Group by 627.

6% during the second quarter. Delta Investment Management LLC now owns 3,798 shares of the healthcare conglomerate’s stock worth $1,934,000 after buying an additional 3,276 shares during the period. 87.

86% of the stock is currently owned by institutional investors and hedge funds. UnitedHealth Group Trading Down 0.2 % Shares of UNH opened at $575.

02 on Friday. The stock’s fifty day simple moving average is $579.08 and its 200 day simple moving average is $523.

25. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.

94. The company has a current ratio of 0.88, a quick ratio of 0.

88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $530.

98 billion, a P/E ratio of 35.15, a price-to-earnings-growth ratio of 1.60 and a beta of 0.

58. UnitedHealth Group Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.

10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.

40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is currently 51.

34%. Insider Activity In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th.

The shares were sold at an average price of $569.88, for a total value of $1,624,727.88.

Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link .

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.

88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.

88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link . Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th.

The shares were sold at an average price of $579.03, for a total transaction of $868,545.00.

Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here .

Insiders own 0.33% of the company’s stock. Analyst Upgrades and Downgrades A number of equities research analysts recently weighed in on the company.

Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th.

Royal Bank of Canada lifted their price target on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th.

StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Truist Financial increased their target price on UnitedHealth Group from $600.

00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Argus upped their price objective on UnitedHealth Group from $570.

00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company.

According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $614.17.

Get Our Latest Analysis on UNH About UnitedHealth Group ( Free Report ) UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated ( NYSE:UNH – Free Report ). Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.

com's FREE daily email newsletter ..